Skip to main content
Clinical Trials/NCT03371160
NCT03371160TerminatedNot Applicable

A Feasibility Study to Evaluate the Clinical Safety of Nutriseal™ Enteral Feeding Tube Placement Using the Nutriseal™ Nutriplace™ System in Patients

Nutriseal L.P2 sites in 1 country22 target enrollmentStarted: December 13, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
22
Locations
2
Primary Endpoint
Number of Participants With Successfully Placed Enteral Feeding Tube

Study Overview

Brief Summary

This is a single center, non-randomized feasibility clinical evaluation that is designed to affirm the safety of the Nutriplace™ System guidance during the placement of the Nutriseal™ enteral feeding tubes.

Detailed Description

Enteral nutrition is the preferred route for the provision of nutritional support in most critical ill patients with functional gastrointestinal tract. Achieving early enteral nutrition (EN) in critically ill patients is associated with fewer major complications, reduced mortality and length of hospital stay, and significant cost savings.

It is estimated that approximately 1.2 million feeding tubes are placed blindly each year in the United States alone. Despite the obvious advantages of the enteral tube feeding, inadvertent placement of enteral feeding tube (EFT) into the airway is relatively common and can result in significant pulmonary injury including pneumothorax and pneumonia. Airway misplacement occurs in 1.2-4 % of blind EFT insertions, with 0.2 to 1.2% of all the feeding tube placements cause pulmonary complications to patients.

The gold standard for detecting inadvertent placement of a feeding tube in the lungs is radiography. However, because of its cost, possible delay of feedings while waiting for radiography, and risk for radiation exposure, clinicians continue to seek for alternative methods to confirm correct placement.

All the above mentioned, emphasizes the fact that safe and effective delivery of nasoenteral tube feedings requires assurance that the feeding tube tip is in a proper position.

The Nutriplace™ System is an electromagnetic tracking system which tracks the path of the feeding tube during placement.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients must be >21 years of age
  • Patients must require placement of a nasoenteral feeding tube
  • Patients have an endotracheal tube, OR Do not have an endotracheal tube but are sedated (RASS score of -2 or less) and/or obtunded (Glasgow Coma scale of 9-12)
  • Patients or legal authorized representative must be able to understand and adhere to all protocol procedures and be willing and able to provide written informed consent

Exclusion Criteria

  • Patients must not have a history of:
  • Esophageal varices or ulcers
  • Upper airway obstruction
  • Upper GI stenosis or obstruction
  • Trauma involving sinuses, nares face or neck that would prevent Nasogastriv (NG) tube insertion
  • Deformities of the sinus cavities and/or skull base
  • Esophageal cancer or neoplasm
  • Patients must not have a significant concomitant illness that would adversely affect their participation in the study
  • Female patients who are pregnant or lactating

Outcomes

Primary Outcomes

Number of Participants With Successfully Placed Enteral Feeding Tube

Time Frame: During procedure visit

Enteral tube (EFT) can be placed in the correct anatomical position without occurrence of guidance-related adverse events. Procedure success was evaluated by comparing tube tip location according to the NUTRIPLACE System and abdominal and/or thoracic X-Ray. Guidance-related AEs were evaluated through the documentation of any guidance-related serious adverse events (SAE) or adverse events (AE) occurring during a subject's participation in the study.

Secondary Outcomes

  • Number of Participants Reporting Retrograde Tube Migration in the Follow-up Visit(During follow-up visit (20-48 hours post tube placement)
  • Number of Participants Requiring Replacement and/or Repositioning of the Feeding Tube(During procedure visit)

Investigators

Sponsor
Nutriseal L.P
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials